Efficacy of iGlarLixi, a fixed‐ratio combination of insulin glargine and lixisenatide, in patients with type 2 diabetes stratified as at high or low risk according to HEDIS measurements
Sugimoto, Danny H., Dex, Terry, Stager, William, Aroda, Vanita R.
Published in Diabetes, obesity & metabolism (01.11.2018)
Published in Diabetes, obesity & metabolism (01.11.2018)
Get full text
Journal Article
A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity
Klinkardt, Ute, Schunk, Mirjam, Ervin, John, Schindler, Christoph, Sugimoto, Danny, Rankin, Bruce, Amann, Ralf, Monti, Martina, Kutschenko, Anna, Schumacher, Carsten, Huber, Kristina, Zeder, Andreas, Heikkila, Nelli, Didierlaurent, Arnaud M, Schwarz, Sylvia E, Derouazi, Madiha
Published in Human vaccines & immunotherapeutics (31.12.2024)
Published in Human vaccines & immunotherapeutics (31.12.2024)
Get full text
Journal Article
Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial
Tronieri, Jena S., Fabricatore, Anthony N., Wadden, Thomas A., Auerbach, Pernille, Endahl, Lars, Sugimoto, Danny, Rubino, Domenica
Published in Obesity facts (01.12.2020)
Published in Obesity facts (01.12.2020)
Get full text
Journal Article
The TRINITY Study: distribution of systolic blood pressure reductions
Sugimoto, Danny H, Chrysant, Steven G, Melino, Michael, Lee, James, Fernandez, Victor, Heyrman, Reinilde
Published in Integrated blood pressure control (01.01.2013)
Published in Integrated blood pressure control (01.01.2013)
Get full text
Journal Article
Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial
Wadden, Thomas A., Tronieri, Jena Shaw, Sugimoto, Danny, Lund, Michael Taulo, Auerbach, Pernille, Jensen, Camilla, Rubino, Domenica
Published in Obesity (Silver Spring, Md.) (01.03.2020)
Published in Obesity (Silver Spring, Md.) (01.03.2020)
Get full text
Journal Article
Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial
Rodbard, Helena W, Lingvay, Ildiko, Reed, John, de la Rosa, Raymond, Rose, Ludger, Sugimoto, Danny, Araki, Eiichi, Chu, Pei-Ling, Wijayasinghe, Nelun, Norwood, Paul
Published in The journal of clinical endocrinology and metabolism (01.06.2018)
Published in The journal of clinical endocrinology and metabolism (01.06.2018)
Get full text
Journal Article
Triple Therapy in Type 2 Diabetes
Julio Rosenstock, Danny Sugimoto, Poul Strange, John A. Stewart, Erika Soltes-Rak, George Dailey
Published in Diabetes care (01.03.2006)
Published in Diabetes care (01.03.2006)
Get full text
Journal Article
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Garvey, W Timothy, Birkenfeld, Andreas L, Dicker, Dror, Mingrone, Geltrude, Pedersen, Sue D, Satylganova, Altynai, Skovgaard, Dorthe, Sugimoto, Danny, Jensen, Camilla, Mosenzon, Ofri
Published in Diabetes care (01.05.2020)
Published in Diabetes care (01.05.2020)
Get full text
Journal Article
Cardiometabolic risk factors efficacy of semaglutide in the STEP program
Amaro, Anastassia, Skolnik, Neil S., Sugimoto, Danny
Published in Postgraduate medicine (14.04.2022)
Published in Postgraduate medicine (14.04.2022)
Get full text
Journal Article
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial
Davies, Melanie J, Bergenstal, Richard, Bode, Bruce, Kushner, Robert F, Lewin, Andrew, Skjøth, Trine Vang, Andreasen, Arne Haahr, Jensen, Christine Bjørn, DeFronzo, Ralph A
Published in JAMA : the journal of the American Medical Association (18.08.2015)
Published in JAMA : the journal of the American Medical Association (18.08.2015)
Get full text
Journal Article
Triple therapy in type 2 diabetes : Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients
ROSENSTOCK, Julio, SUGIMOTO, Danny, STRANGE, Poul, STEWART, John A, SOLTES-RAK, Erika, DAILEY, George
Published in Diabetes care (01.03.2006)
Published in Diabetes care (01.03.2006)
Get full text
Journal Article
Effects of IDegLira (Insulin Degludec/Liraglutide) in Patients with Poorly Controlled Type 2 Diabetes (T2D) with A1C >9%—Analyses from the DUAL Program
SUGIMOTO, DANNY, FRIAS, JUAN P., GOUET, DIDIER, TAKÁCS, RÓBERT, JIA, TING, ÖRSY, PETRA, BAIN, STEPHEN C.
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article
1003-P: Clinical Response (HbA1c ≥1% and/or Body Weight ≥5% Reduction) to Semaglutide by Baseline HbA1c and Body Weight in the SUSTAIN Program
ARODA, VANITA R., LARSEN, JULIE F., ØSTOFT, SIGNE HARRING, REA, ROSANGELA R., SUGIMOTO, DANNY, ZIEGLER, UWE, VILSBØLL, TINA
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article
Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy
Hollander, Priscilla, Sugimoto, Danny, Vlajnic, Aleksandra, Kilo, Charles
Published in Journal of diabetes and its complications (01.11.2015)
Published in Journal of diabetes and its complications (01.11.2015)
Get full text
Journal Article
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26weeks' treatment: A randomized open label study
Christofides, Elena A, Puente, Orlando, Norwood, Paul, Denham, Douglas, Maheshwari, Hiralal, Lillestol, Michael, Hart, Terence, Nakhle, Samer, Chadha, Anurekha, David Fitz‐Patrick, Sugimoto, Danny, Soufer, Joseph, Young, Douglas, Warren, Mark, Huffman, David, Reed, John, Bays, Harold, Arora, Samir, Rizzardi, Barbara, Tidman, Raymond, Rendell, Marc, Johnson, Kimball A
Published in Diabetes, obesity & metabolism (01.06.2024)
Published in Diabetes, obesity & metabolism (01.06.2024)
Get full text
Journal Article
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study
Christofides, Elena A., Puente, Orlando, Norwood, Paul, Denham, Douglas, Maheshwari, Hiralal, Lillestol, Michael, Hart, Terence, Nakhle, Samer, Chadha, Anurekha, Fitz‐Patrick, David, Sugimoto, Danny, Soufer, Joseph, Young, Douglas, Warren, Mark, Huffman, David, Reed, John, Bays, Harold, Arora, Samir, Rizzardi, Barbara, Tidman, Raymond, Rendell, Marc, Johnson, Kimball A.
Published in Diabetes, obesity & metabolism (01.06.2024)
Published in Diabetes, obesity & metabolism (01.06.2024)
Get full text
Journal Article
IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy
Miller, Eden, Doshi, Ankur, Grøn, Randi, Jódar, Esteban, Őrsy, Petra, Ranthe, Mattis F., Sugimoto, Danny, Tentolouris, Nikolaos, Viljoen, Adie, Billings, Liana K.
Published in Diabetes, obesity & metabolism (01.12.2019)
Published in Diabetes, obesity & metabolism (01.12.2019)
Get full text
Journal Article
EFFICACY AND SAFETY OF SEMAGLUTIDE IN ELDERLY SUBJECTS WITH TYPE 2 DIABETES: A POST HOC ANALYSIS OF THE SUSTAIN 7 TRIAL
Aroda, Vanita, Sugimoto, Danny, Trachtenbarg, David, Warren, Mark, Nayak, Gurudutt, Navarria, Andrea, Woo, Vincent
Published in Endocrine practice (01.04.2018)
Get full text
Published in Endocrine practice (01.04.2018)
Journal Article
Abstract #239 Insulin Degludec/Liraglutide (Ideglira) Achieved Non-Inferior A1c Reduction; Weight Loss and Fewer Hypoglycemic Episodes while Using a Simple Regimen with Fewer Injections and Dose Adjustments Compared with Basal–Bolus Therapy: An Analysis of Dual VII
Miller, Eden, Jodar, Esteban, Khunti, Kamlesh, Sugimoto, Danny, Örsy, Petra, Ranthe, Mattis, Viljoen, Adie
Published in Endocrine practice (01.04.2018)
Published in Endocrine practice (01.04.2018)
Get full text
Journal Article